Israele
Vai alla Scheda Paese »You can follow goals as small as those of your ego, or as big as those of your ideas.
— Shimon Peres
You can follow goals as small as those of your ego, or as big as those of your ideas.
— Shimon Peres
Business in Brief: Real estate developer Gazit-Globe swings to profit in Q3; Bezeq Israel Telecom releases Q3 results; Discount Investment to get year-end boost with Adama sale; Tel Aviv shares edge downward.
Strauss net up 7% in 3rd quarter, sees $5 million hit from U.S. recall in 4th; Mizrahi Tefahot unveils business plan with goal of boosting market share and dividend; Tel Aviv follows world stock markets higher.
Teva gets European approval for drug to treat aggressive form of leukemia | Four U.S. developers eye combined NIS 1.7 billion in bond issues | Tel Aviv ends higher, led by insurance stocks
Los Angeles-based Saidoff brothers make offer for Africa Israel Investments; Cellcom pushed to remove Michael Golan from talks to sell Golan Telecom; Tech and telco stocks send Tel Aviv higher.
La proposta di legge per legalizzare gli insediamenti ebraici in Cisgiordania arriva al parlamento israeliano. Si tratta ancora di una lettura preliminare, ma anche solo la discussione della proposta, avanzata dai ministri di estrema destra, ha un enorme significato simbolico e mette in difficoltà l’esecutivo di Benjamin Netanyahu, non solo ...
La proposta di legge per legalizzare gli insediamenti ebraici in Cisgiodania arriva al parlamento israeliano. Si tratta ancora di una lettura preliminare, ma anche solo la discussione della proposta, avanzata dai ministri di estrema destra, ha un enorme significato simbolico e mette in difficoltà l’esecutivo di Benjamin Netanyahu, non solo ...
Teva shares hammered a second day after disappointing third quarter | After two tough quarters, Delta-Galil profit climbs 31% | Tel Aviv has another quiet day as Wall Street opens lower
Teva outpaces forecasts for third-quarter earnings, but lowers outlook; Stratasys shares plunge on disappointing quarterly results; Salaries for top executives at TASE-listed companies fell in 2015; Tel Aviv shares tread water for another day.
Il 13 novembre i ministri del governo israeliano hanno approvato un testo di legge che permetterebbe di legalizzare alcuni tipi di colonie in Cisgiordania, nonostante l’opposizione del primo ministro Benjamin Netanyahu. Leggi
Israele dovrà demolire l’insediamento di Amona in Cisgiordania. Il governo aveva chiesto di rinviare l’operazione oltre la scadenza del 25 dicembre, ma la corte suprema israeliana ha bocciato la richiesta. Intanto, il 13 novembre i ministri israeliani hanno approvato un disegno di legge per legalizzare gli insediamenti in Cisgiordania.
In Israele i ministri approvano un disegno di legge per legalizzare gli insediamenti in Cisgiordania. Il 13 novembre la commissione ministeriale per la legislazione ha approvato un testo promosso dal ministro dell’istruzione Naftali Bennett, del partito dei coloni Casa ebraica. Se fosse approvata dal parlamento, la legge permetterebbe di legalizzare ...
Perrigo says it’s exploring options for its Tysabri multiple sclerosis drug; SodaStream shares reach two-year high on jump in profits; Nice Systems tops profit forecast, raises outlook for 2016.
The Tel Aviv Stock Exchange will continue to operate Sunday-Thursday after the change in its ownership structure.
| Teva shares gain after big loss on U.S. probe | Imperva says it will remain independent | Tel Aviv shares gain for first time in 9 days.
Spacecom expects $196 million payment for Amos 6 loss by November 24; CyberArk shares climb after strong third-quarter earnings; Teva Pharmaceuticals pushes the Tel Aviv market lower.
Federal Circuit revives Amdocs’ data mediation software patents; Tel Aviv Stock Exchange closes with losses.
Check Point bests forecasts for third-quarter results; Profits at Discount New York plunged in the third quarter; Teva trades heavily as ETFs bail out of drug maker’s Tel Aviv shares.
ReWalk shares plunge on securities offering; Courts approves class action suit against Shemen, Gabi Ashkenazi; Tel Aviv shrugs off Wall Street gains to end.
Chinese companies reach deals with Insuline and Foresight; Teva, IBM expand health tech partnership; Tel Aviv shares follow world markets lower.
TASE hires a private eye but won’t say why | Pluristem rallies after Chinese investor take stake | Biomed stocks lead Tel Aviv higher.
Imperva shares drop on report that selling process has stalled; Most global rights to Pango Plus parking app sold to Spanish company; Tel Aviv shares end mixed in dull trading.